Medical program: Treating inflammation for ASCVD-risk?

Media formats available:

Bempedoic acid: effective tool in the toolkit for LDL-c lowering
Bempedoic acid: effective tool in the toolkit for LDL-c lowering
EAS 2024
Bempedoic acid: effective tool in the toolkit for LDL-c lowering
- Stephen Nicholls, FRACP, FACC, FESC, FAHA
Causal relationship between elevated Lp(a) levels and CKD risk
Causal relationship between elevated Lp(a) levels and CKD risk
EAS 2024
Causal relationship between elevated Lp(a) levels and CKD risk
- Anne Langsted, MD, PhD
LDL-c lowering with PCSK9 inhibitor in ASCVD patients without acute ischemic event
LDL-c lowering with PCSK9 inhibitor in ASCVD patients without acute ischemic event
EAS 2024
LDL-c lowering with PCSK9 inhibitor in ASCVD patients without acute ischemic event
- Pasquale Perrone-Filardi, MD, PhD
Rationale for dietary fat recommendations in ASCVD prevention
Rationale for dietary fat recommendations in ASCVD prevention
EAS 2024
Rationale for dietary fat recommendations in ASCVD prevention
- Jacob J. Christensen, PhD

Pro/con debate: Are we ready to treat inflammation for ASCVD prevention?